DURECT Corporation (NASDAQ:DRRX) to Hold Q3 2008 Earnings Conference Call November 3

DURECT Corporation (NASDAQ:DRRX) will hold a conference call on Monday, November 3 at 4:30 pm ET to discuss the third quarter earnings for 2008.  A webcast of the presentation will be available on the Investor Relations section of the company’s website at durect.com.

DURECT Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s pharmaceutical systems enable optimized therapy for a given disease or patient population by controlling the rate and duration of drug administration, as well as for certain applications, placement of the drug at the intended site of action.

DURECT Corporation’s drug delivery technology platforms include SABER Delivery System, ORADUR Delivery System, TRANSDUR Delivery System, DURIN Biodegradable Implant, DUROS System and MICRODUR. The Company’s development efforts are focused on the application of its pharmaceutical systems technologies to products in a variety of chronic and episodic disease areas, including pain, central nervous system (CNS) disorders, cardiovascular disease and other chronic diseases.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.

The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.

Create your profile on The Global Market Directory